Sg3 Management, LLC Merck & Co., Inc. Call Options Transaction History

Sg3 Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $648,522 - $723,618	-6,300 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$84.53 - $94.96 $532,539 - $598,248	6,300 New	6,300 $542,000
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $6.08 Million - $6.89 Million	-72,800 Reduced 92.04%	6,300 $574,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $5.15 Million - $5.77 Million	-70,000 Reduced 46.95%	79,100 $6.49 Million
Q4 2021 Feb 15, 2022	BUY	$72.28 - $90.54 $7.94 Million - $9.94 Million	109,800 Added 279.39%	149,100 $11.4 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $1.62 Million - $1.78 Million	22,600 Added 135.33%	39,300 $2.95 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $4.2 Million - $4.95 Million	-61,000 Reduced 78.51%	16,700 $1.29 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $5.69 Million - $6.45 Million	77,700 New	77,700 $6.45 Million
Q1 2018 May 11, 2018	SELL	$50.96 - $59.23 $764,400 - $888,450	-15,000 Closed	0 $0
Q4 2017 Feb 26, 2018	BUY	$51.62 - $61.64 $766,557 - $915,354	14,850 Added 9900.0%	15,000 $844,000
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $7,743 - $9,246	150	150 $19,000

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.